Venus Medtech (Hangzhou) Inc. (2500) Announces Patent Infringement Lawsuit Filing in Delaware

Bulletin Express
01/22

Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.

The Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.

The announcement is dated January 20, 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10